109 related articles for article (PubMed ID: 31238376)
21. Network-based approach for drug repurposing against mpox.
Tang K; Sun Q; Zeng J; Tang J; Cheng P; Qiu Z; Long H; Chen Y; Zhang C; Wei J; Qiu X; Jiang G; Fang Q; Sun L; Sun C; Du X
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132468. PubMed ID: 38761900
[TBL] [Abstract][Full Text] [Related]
22. MeSHDD: Literature-based drug-drug similarity for drug repositioning.
Brown AS; Patel CJ
J Am Med Inform Assoc; 2017 May; 24(3):614-618. PubMed ID: 27678460
[TBL] [Abstract][Full Text] [Related]
23. Old wine in new bottles: Drug repurposing in oncology.
Antoszczak M; Markowska A; Markowska J; Huczyński A
Eur J Pharmacol; 2020 Jan; 866():172784. PubMed ID: 31730760
[TBL] [Abstract][Full Text] [Related]
24. Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases.
Kingsmore KM; Grammer AC; Lipsky PE
Nat Rev Rheumatol; 2020 Jan; 16(1):32-52. PubMed ID: 31831878
[TBL] [Abstract][Full Text] [Related]
25. DDCM: A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm.
Xu M; Li W; He J; Wang Y; Lv J; He W; Chen L; Zhi H
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791306
[TBL] [Abstract][Full Text] [Related]
26. Drug target gene-based analyses of drug repositionability in rare and intractable diseases.
Sakate R; Kimura T
Sci Rep; 2021 Jun; 11(1):12338. PubMed ID: 34117295
[TBL] [Abstract][Full Text] [Related]
27. A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer.
Yang C; Zhang H; Chen M; Wang S; Qian R; Zhang L; Huang X; Wang J; Liu Z; Qin W; Wang C; Hang H; Wang H
Elife; 2022 Feb; 11():. PubMed ID: 35191375
[TBL] [Abstract][Full Text] [Related]
28. A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures.
Mokou M; Narayanasamy S; Stroggilos R; Balaur IA; Vlahou A; Mischak H; Frantzi M
Methods Mol Biol; 2023; 2684():59-99. PubMed ID: 37410228
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Drug Repositioning and Prediction Techniques: A Concise Review.
He S; Liu X; Ye X; Tetsuya S
Curr Top Med Chem; 2022; 22(23):1897-1906. PubMed ID: 35301952
[TBL] [Abstract][Full Text] [Related]
30. A comprehensive evaluation of connectivity methods for L1000 data.
Lin K; Li L; Dai Y; Wang H; Teng S; Bao X; Lu ZJ; Wang D
Brief Bioinform; 2020 Dec; 21(6):2194-2205. PubMed ID: 31774912
[TBL] [Abstract][Full Text] [Related]
31. Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma.
Sagers JE; Brown AS; Vasilijic S; Lewis RM; Sahin MI; Landegger LD; Perlis RH; Kohane IS; Welling DB; Patel CJ; Stankovic KM
Sci Rep; 2018 Apr; 8(1):5437. PubMed ID: 29615643
[TBL] [Abstract][Full Text] [Related]
32. Overcoming Sparseness of Biomedical Networks to Identify Drug Repositioning Candidates.
Poleksic A
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(4):2377-2384. PubMed ID: 33591920
[TBL] [Abstract][Full Text] [Related]
33. The functional therapeutic chemical classification system.
Croset S; Overington JP; Rebholz-Schuhmann D
Bioinformatics; 2014 Mar; 30(6):876-83. PubMed ID: 24177719
[TBL] [Abstract][Full Text] [Related]
34. From gene networks to drugs: systems pharmacology approaches for AUD.
Ferguson LB; Harris RA; Mayfield RD
Psychopharmacology (Berl); 2018 Jun; 235(6):1635-1662. PubMed ID: 29497781
[TBL] [Abstract][Full Text] [Related]
35. The Pharmacorank Search Tool for the Retrieval of Prioritized Protein Drug Targets and Drug Repositioning Candidates According to Selected Diseases.
Gnilopyat S; DePietro PJ; Parry TK; McLaughlin WA
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358909
[TBL] [Abstract][Full Text] [Related]
36. A Gene Co-Expression Network-Based Drug Repositioning Approach Identifies Candidates for Treatment of Hepatocellular Carcinoma.
Yuan M; Shong K; Li X; Ashraf S; Shi M; Kim W; Nielsen J; Turkez H; Shoaie S; Uhlen M; Zhang C; Mardinoglu A
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326724
[TBL] [Abstract][Full Text] [Related]
37. Session Introduction: Drug-repurposing and discovery in the era of "big" real-world data: how the incorporation of observational data, genetics, and other -omic technologies can move us forward.
Shuey MM; Hellwege JN; Khankari N; Vujkovic M; Edwards TL
Pac Symp Biocomput; 2024; 29():226-231. PubMed ID: 38160282
[TBL] [Abstract][Full Text] [Related]
38. A Computational Systems Biology Approach for Identifying Candidate Drugs for Repositioning for Cardiovascular Disease.
Yu AZ; Ramsey SA
Interdiscip Sci; 2018 Jun; 10(2):449-454. PubMed ID: 27778232
[TBL] [Abstract][Full Text] [Related]
39. Exploration of databases and methods supporting drug repurposing: a comprehensive survey.
Tanoli Z; Seemab U; Scherer A; Wennerberg K; Tang J; Vähä-Koskela M
Brief Bioinform; 2021 Mar; 22(2):1656-1678. PubMed ID: 32055842
[TBL] [Abstract][Full Text] [Related]
40. NOGEA: A Network-oriented Gene Entropy Approach for Dissecting Disease Comorbidity and Drug Repositioning.
Guo Z; Fu Y; Huang C; Zheng C; Wu Z; Chen X; Gao S; Ma Y; Shahen M; Li Y; Tu P; Zhu J; Wang Z; Xiao W; Wang Y
Genomics Proteomics Bioinformatics; 2021 Aug; 19(4):549-564. PubMed ID: 33744433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
